USFDA inspects Divi’s Laboratories’ Unit-I facility at Telangana

15 Nov 2019 Evaluate

Divi’s Laboratories’ Unit-I facility at Lingojigudem, Bhuvanagiri Yadadri District, Telangana has been inspected by the US Food and Drug Administration (USFDA) from the November 11, 2019 to November 15, 2019. This inspection was a general cGMP inspection by the USFDA. The inspection has been concluded with no 483 observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.


Divis Lab Share Price

6328.70 -65.95 (-1.03%)
01-Jan-2026 14:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.75
Dr. Reddys Lab 1249.75
Cipla 1499.90
Zydus Lifesciences 915.00
Lupin 2102.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×